2094-72-6 | 1-Adamantanecarbonyl chloride

Packsize	Purity	Availability	Price	Discounted Price
1g	97%	in stock	$25.00	$18.00
5g	97%	in stock	$41.00	$29.00
25g	97%	in stock	$162.00	$113.00

Description

• Catalog Number: AB19334
• Chemical Name: 1-Adamantanecarbonyl chloride
• CAS Number: 2094-72-6
• Molecular Formula: C11H15ClO
• Molecular Weight: 198.6892
• MDL Number: MFCD00074724
• SMILES: ClC(=O)C12CC3CC(C2)CC(C1)C3

Computed Properties

• Complexity: 218
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 13
• Hydrogen Bond Acceptor Count: 1
• Rotatable Bond Count: 1
• XLogP3: 3.6

Literature

• (1-Adamant-yl)(2-methyl-phen-yl)methanone.

  Acta crystallographica. Section E, Structure reports online 20101201

• Facile fabrication of narrowly-distributed polymeric micelles via host-guest inclusion complexation of hyperbranched polymers and cyclodextrin and its two-dimensional self-assembly.

  Physical chemistry chemical physics : PCCP 20101014

• 2-(1-Adamant-yl)-1,3-diphenyl-propan-2-ol.

  Acta crystallographica. Section E, Structure reports online 20100801

• (1-Adamant-yl)diphenyl-methano-l.

  Acta crystallographica. Section E, Structure reports online 20100701

• N-p-Tolyladamantane-1-carboxamide.

  Acta crystallographica. Section E, Structure reports online 20091001

• N-Butyladamantane-1-carboxamide.

  Acta crystallographica. Section E, Structure reports online 20091001

• 3-(1-Adamant-yl)-6-methyl-3-(3-methyl-benz-yl)isochroman-1-one.

  Acta crystallographica. Section E, Structure reports online 20090601

• A new polymorph of N-(prop-2-yn-yl)tricyclo-[3.3.1.1]decane-1-carbox-amide.

  Acta crystallographica. Section E, Structure reports online 20080801

• Preparation and preliminary evaluation of novel beta-cyclodextrin/IUDR prodrug formulations.

  Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20080618

• Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1,3,4-thiadiazoles.

  European journal of medicinal chemistry 20070201